These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 11365053)
1. What's new and what's next. Fakuda D Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053 [TBL] [Abstract][Full Text] [Related]
2. Four new antiretroviral medications will soon offer more options to HIV patients. Murphy MJ Fac Notes (New Orleans La); 1998; 10(4):1-3. PubMed ID: 11365545 [TBL] [Abstract][Full Text] [Related]
4. Protease inhibitor failure trial: combination 1592, 141W94, and efavirenz. AIDS Treat News; 1997 Dec; (No 284):4. PubMed ID: 11364914 [TBL] [Abstract][Full Text] [Related]
5. What's new, what's next? Elwell A Posit Dir News; 1999; 11(1):1, 3-13. PubMed ID: 11366098 [TBL] [Abstract][Full Text] [Related]
6. Novel approaches for the treatment of HIV. Arroyo HT Newsline People AIDS Coalit N Y; 1998 Mar; ():16-7. PubMed ID: 11367450 [TBL] [Abstract][Full Text] [Related]
7. Drifting agenda for federal treatment research. Huff B GMHC Treat Issues; 2001 May; 15(5):1-4. PubMed ID: 11548299 [No Abstract] [Full Text] [Related]
8. New drugs in development. Proj Inf Perspect; 1998 Sep; (25):8. PubMed ID: 11365851 [TBL] [Abstract][Full Text] [Related]
9. Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker. Follansbee S; Deeks S; Bartnoff H Newsline People AIDS Coalit N Y; 1998 Mar; ():7-14. PubMed ID: 11367453 [TBL] [Abstract][Full Text] [Related]
10. Selected highlights from the 5th Conference on Retroviruses and Opportunistic Infections. Bartnof HS BETA; 1998 Apr; ():49-56. PubMed ID: 11365269 [TBL] [Abstract][Full Text] [Related]
11. The new drugs and how to use them. Gallant JE Hopkins HIV Rep; 1999 Jan; 11(1):2, 7. PubMed ID: 11366160 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks. Wasmuth JC; Herhaus C; Römer K; Salzberger B; Kaiser R; Schliefer K; Voigt E; Rockstroh JK AIDS; 2002 May; 16(7):1077-8. PubMed ID: 11953478 [No Abstract] [Full Text] [Related]
14. I want a new drug. An overview of three new anti-HIV drugs. Simmons P Res Initiat Treat Action; 1998 Jun; 4(3):9-11. PubMed ID: 11365539 [TBL] [Abstract][Full Text] [Related]
15. New expanded access drugs for use in combination therapy. Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823 [TBL] [Abstract][Full Text] [Related]
16. [HIV infections: mortality reduced only in developed countries]. Wehr A Dtsch Med Wochenschr; 1999 May; 124(18):A8-9. PubMed ID: 10356577 [No Abstract] [Full Text] [Related]
17. Clinical update: new drugs for HIV/AIDS. Gracia Jones S; Baggett TH Medsurg Nurs; 1999 Apr; 8(2):108-12. PubMed ID: 10410008 [TBL] [Abstract][Full Text] [Related]
18. The medical merry-go-round: drugs for 1998 are new but not novel. Gilden D GMHC Treat Issues; 1997-1998 Winter; 12(1):18-25. PubMed ID: 11364984 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral update from the Interscience Conference on Antimicrobial Agents and Chemotherapy. Newsline People AIDS Coalit N Y; 1998 Dec; ():16-8. PubMed ID: 11367083 [TBL] [Abstract][Full Text] [Related]
20. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults. Lalezari JP; DeJesus E; Northfelt DW; Richmond G; Wolfe P; Haubrich R; Henry D; Powderly W; Becker S; Thompson M; Valentine F; Wright D; Carlson M; Riddler S; Haas FF; DeMasi R; Sista PR; Salgo M; Delehanty J Antivir Ther; 2003 Aug; 8(4):279-87. PubMed ID: 14518696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]